Chat with us, powered by LiveChat

January 2021

Working together to address the potential presence of nitrosamine impurities in medications

Lhasa Limited, in collaboration with Leadscope, Inc., are leading a working group of pharmaceutical toxicologists and consultants investigating the carcinogenic potency and structure-activity relationships of N-nitrosamines. This is in response to the recent discovery of N-nitrosamines in marketed pharmaceuticals and the regulatory changes that have resulted. The working group is coordinated on an informal basis […]

Working together to address the potential presence of nitrosamine impurities in medications Read More »

Lhasa Limited CEO, Dr. Chris Barber, reflects on 2020 and shares plans for the year ahead

The global pandemic has undoubtedly had a huge impact on many companies in 2020, Lhasa is no exception. I am immensely proud of my Lhasa colleagues’ resilience during the remote working situation we all found ourselves in, demonstrated, in part, through the continued release of both software and knowledge to our members throughout 2020. If

Lhasa Limited CEO, Dr. Chris Barber, reflects on 2020 and shares plans for the year ahead Read More »